Introduction
Patents motivate invention. One of the purposes of granting patents is that it may incentivise the
inventor and in turn encourage other individuals to perform similar inventions. Patents grant the
inventors with some exclusive privileges over the invention so that he may reap the fruits of his
labour. However, in the pharmaceutical industry more safeguards are needed so that no one can
use the IPR regime to his benefit.
This essay throws light over how the present Intellectual Property Laws are tactfully used by
pharmaceutical corporations to their benefit. Towards the conclusion the researcher examines
the ways to prevent it and make access to medicines more readily.
Pharmaceutical Industry thrives and expands through protection of intellectual property rights
involved with regard to the pharmaceutical products. The patent law is the key to its growth.1
1 Juan He, Indian Patent Law and Its Impact on the Pharmaceutical Industry: What Can China Learn from India?, INNOVATION, ECONOMIC DEVELOPMENT, AND INTELLECTUAL PROPERTY IN INDIA AND CHINA 251–269 (2019).
2 David Taylor, The Pharmaceutical Industry and the Future of Drug Development, ISSUES IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY 1–33 (2019), https://pubs.rsc.org/en/content/chapterhtml/2015/bk9781782621898-00001?isbn=978-1-78262-189- 8&sercode=bk.
3 European Commission (2009) Pharmaceutical sector inquiry final report. http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/staff_working_paper_part1.pdf. Accessed 31 Jan
2021.
4 Olga Gurgula, Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?, 51 IIC - INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW 1062–1085 (2020).
5 Harsha Agarwal, Secondary patenting or evergreening: indian ip perspective SAGACIOUS IP (2020), https://sagaciousresearch.com/blog/secondary-patenting-or-evergreening-india/ (last visited Dec 31, 2021).
6 What’s the difference between brand-name and generic prescription drugs?, SCIENTIFIC AMERICAN (2004), https://www.scientificamerican.com/article/whats-the-difference-betw-2004-12-13/ (last visited Dec 31, 2021).
7 Himanshu Gupta et al., Patent protection strategies, 2 JOURNAL OF PHARMACY AND BIOALLIED SCIENCES 2 (2010), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146086/ (last visited Dec 31, 2021).
8 Neha Dasgupta, Exclusive: With U.S. trade under a cloud, China opens to Indian pharma, REUTERS (2018), https://www.reuters.com/article/us-usa-trade-china-india-exclusive/exclusive-with-us-trade-under-a-cloud-chinaopens-to-indian-pharma-idUSKBN1K20IF (last visited Dec 31, 2021).